Technology | Radiographic Fluoroscopy (RF) | March 15, 2018

Two-in-one digital radiography-fluoroscopy system provides low-dose, high-quality images while supporting fast workflow, broadening clinical capacity and increasing room utilization

Philips Receives FDA Clearance for ProxiDiagnost N90 DRF System

March 15, 2018 – Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ProxiDiagnost N90, its newest premium digital radiography-fluoroscopy (DRF) system. With its ability to perform both nearby fluoroscopy and digital X-rays through a single system, ProxiDiagnost N90 supports high room utilization and increased patient throughput, while also providing outstanding workflow support and patient accessibility.  

Benefits of the new system for both patients and staff include:

  • Enhanced image quality – The ProxiDiagnost N90 provides high-quality images with premium flat detector technology and the new dynamic UNIQUE image processing, thanks to which sequences are stable and harmonized from the first frame to the end. This eliminates the need for several frames to produce a usable image and make a confident diagnosis.   
  • Support for staff workflow – With support for nearby use, ProxiDiagnost N90 allows technologists to conduct procedures next to the patient, in keeping with common workflow and to improve the patient experience. The system also features the Philips Eleva user interface, allowing clinicians familiar with the design to use the system immediately without additional training due to Philips’ platform approach for the design of its premium portfolio.
  • Greater patient accessibility – Thoughtful design, including a small footprint and an open overhead area and table, enables technologists or caregivers to be closer to the patient during procedures. This is especially important for pediatric and elderly patients, or others who may need additional support to remain calm during the procedure.
  • For pediatric examinations – Philips’ Grid-Controlled Fluoroscopy (GCF) enables a dose rate reduction up to 68 percent [1] compared to pulse controlled fluoroscopy (PCF), depending on patient type and clinical application.

For more information: www.usa.philips.com/healthcare

[1] Relative difference of two reference air kerma rates between system with GCF and system with PCF.

 


Related Content

News | Orthopedic Imaging

Nov.10, 2025 — Medical imaging technology company Adaptix Ltd. has received 510(k) clearance from the U.S. Food and Drug ...

Time November 11, 2025
arrow
News | Proton Therapy

Sept. 28, 2025 — Leo Cancer Care has launched Grace, the company's upright photon therapy system. Grace is named after ...

Time October 03, 2025
arrow
News | Bone Densitometry Systems

Sept. 11, 2025 — Naitive Technologies, a medical technology company developing AI-driven software to reimagine ...

Time September 11, 2025
arrow
News | Mammography

Aug. 19, 2025 — Calidar, Inc., a start-up in precision diagnostic imaging formed out of Duke University, recently ...

Time August 19, 2025
arrow
Feature | X-Ray | By Siân Phillips, MD

Imaging is a crucial diagnostic, treatment and monitoring tool in modern medicine. From diagnosis to disease management ...

Time July 31, 2025
arrow
News | Artificial Intelligence

May 6, 2025 — NewVue.ai, a leader in cloud-native radiology workflow orchestration, and MD.ai, a pioneer in AI-enhanced ...

Time May 06, 2025
arrow
News | X-Ray

May 01, 2025 — Researchers from the Rajpurkar Lab in the Department of Biomedical Informatics at Harvard Medical School ...

Time May 01, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Digital Radiography (DR)

Feb. 12, 2025 — Konica Minolta Healthcare Americas, has published a case study by clinicians in the pulmonary and ...

Time February 14, 2025
arrow
Subscribe Now